Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 1181: Which of the following antiretroviral drugs is a non-nucleoside reverse transcriptase inhibitor?

A. Zidovudine
B. Efavirenz (Correct Answer)
C. Saquinavir
D. Stavudine

Explanation: ### Explanation **Correct Answer: B. Efavirenz** **Mechanism and Classification:** Antiretroviral therapy (ART) is classified based on the stage of the HIV life cycle the drugs inhibit [2]. **Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)** like **Efavirenz** bind directly and non-competitively to the enzyme reverse transcriptase at a site distinct from the active site (allosteric site). This induces a conformational change that inhibits the conversion of viral RNA to DNA. Unlike NRTIs, NNRTIs do not require intracellular phosphorylation to become active. **Analysis of Incorrect Options:** * **A. Zidovudine (AZT) & D. Stavudine (d4T):** These are **Nucleoside Reverse Transcriptase Inhibitors (NRTIs)** [3]. They act as competitive inhibitors and "chain terminators" [1]. They are structural analogs of native nucleosides and must be phosphorylated by host cell kinases into triphosphate forms to be active [1]. * **C. Saquinavir:** This is a **Protease Inhibitor (PI)** [3]. It inhibits the viral protease enzyme, preventing the cleavage of precursor polyproteins (gag-pol), which results in the production of immature, non-infectious virions [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Efavirenz Side Effects:** Characteristically causes **CNS side effects** (vivid dreams, nightmares, dizziness, and "hangover" feeling). It is also associated with **teratogenicity** (neural tube defects), though recent guidelines have relaxed restrictions in pregnancy. * **Nevirapine (another NNRTI):** Known for causing severe hepatotoxicity and Stevens-Johnson Syndrome (SJS) [4]. It was historically used to prevent mother-to-child transmission (MTCT). * **Mnemonic for NNRTIs:** "**DEN**" – **D**elavirdine, **E**favirenz, **N**evirapine (and newer agents like Etravirine and Rilpivirine). * **Zidovudine** is specifically known for causing **bone marrow suppression** (anemia/neutropenia).

Question 1182: Which of the following can be given as a single dose antimalarial for P.vivax malaria?

A. Atovaquone + Proguanil
B. Artemisinin
C. Quinine + Tetracycline
D. Pyrimethamine + Sulfadoxime (Correct Answer)

Explanation: **Explanation:** The combination of **Pyrimethamine and Sulfadoxime (S/P)** is characterized by an exceptionally long half-life (Sulfadoxime ~7–9 days; Pyrimethamine ~4 days). This pharmacological profile allows for **single-dose administration**, ensuring high patient compliance. It acts via sequential blockade of folic acid synthesis, targeting the erythrocytic schizonts of malaria parasites. While primarily used for *P. falciparum*, it is also effective against the erythrocytic stages of *P. vivax*. **Analysis of Incorrect Options:** * **A. Atovaquone + Proguanil:** This combination (Malarone) requires a **3-day course** for treatment or daily administration for prophylaxis. It is not used as a single dose. * **B. Artemisinin:** Artemisinin derivatives (like Artesunate or Artemether) have very short half-lives. When used as monotherapy, they require at least 5–7 days of treatment; in ACT (Artemisinin-based Combination Therapy), they are typically given for **3 days**. * **C. Quinine + Tetracycline:** Quinine has a short half-life and narrow therapeutic index, requiring dosing every 8 hours for **7 days**. Tetracycline also requires a 7-day course. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** S/P inhibits Dihydrofolate Reductase (Pyrimethamine) and Dihydropteroate Synthase (Sulfadoxime). * **Radical Cure:** Note that while S/P treats the blood stage of *P. vivax*, a **14-day course of Primaquine** (or a single dose of **Tafenoquine**) is mandatory to clear the **hypnozoites** (liver stage) and prevent relapse. * **Contraindication:** Avoid S/P in patients with sulfa allergies or severe renal/hepatic failure. It is also avoided in the first trimester of pregnancy due to antifolate effects.

Question 1183: Among the drugs listed, which is LEAST likely to be implicated in drug-induced hepatitis?

A. Isoniazid
B. Streptomycin (Correct Answer)
C. Rifampicin
D. Pyrazinamide

Explanation: **Explanation:** The core concept in this question is the distinction between **Hepatotoxic** and **Non-hepatotoxic** Anti-Tubercular Drugs (ATD). **Why Streptomycin is the correct answer:** Streptomycin is an **Aminoglycoside**. Unlike the first-line oral agents, it is primarily excreted unchanged by the kidneys via glomerular filtration. It does not undergo significant hepatic metabolism and, therefore, lacks the potential for drug-induced liver injury (DILI). Its primary toxicities are **ototoxicity** (vestibulocochlear nerve damage) and **nephrotoxicity**. **Analysis of Incorrect Options:** * **Pyrazinamide (D):** This is the **most hepatotoxic** drug among the first-line ATD regimen. It causes dose-dependent hepatotoxicity and can lead to severe liver necrosis. * **Isoniazid (A):** It is a major cause of drug-induced hepatitis. Toxicity is mediated by its metabolite, **acetylhydrazine**. The risk is higher in "slow acetylators" and older patients. * **Rifampicin (C):** While less hepatotoxic than Pyrazinamide or Isoniazid, it is a potent **enzyme inducer**. It can cause transient asymptomatic jaundice and often potentiates the hepatotoxicity of Isoniazid by increasing the formation of toxic metabolites. **NEET-PG High-Yield Pearls:** 1. **Hepatotoxicity Order:** Pyrazinamide > Isoniazid > Rifampicin. 2. **Safe in Liver Disease:** If a patient develops jaundice during ATT, the hepatotoxic drugs (H, R, Z) are stopped. The safest alternatives are **Streptomycin** and **Ethambutol**. 3. **Visual Side Effects:** Remember that Ethambutol is associated with optic neuritis (red-green color blindness), not hepatitis. 4. **Monitoring:** If ALT/AST levels rise to >3 times the upper limit of normal with symptoms, or >5 times without symptoms, hepatotoxic drugs must be discontinued.

Question 1184: Which of the following is NOT included in the treatment of Mycobacterium avium complex?

A. Ciprofloxacin
B. Clarithromycin
C. Rifabutin
D. Pyrazinamide (Correct Answer)

Explanation: **Explanation:** The **Mycobacterium avium complex (MAC)** consists of *M. avium* and *M. intracellulare*. Unlike *Mycobacterium tuberculosis*, MAC is **intrinsically resistant** to most standard first-line antitubercular drugs, most notably **Pyrazinamide**. 1. **Why Pyrazinamide (D) is the correct answer:** Pyrazinamide requires an acidic environment and the enzyme pyrazinamidase to be converted into its active form (pyrazinoic acid). MAC lacks the specific susceptibility mechanisms required for Pyrazinamide to be effective; therefore, it has no role in the treatment of MAC infections. 2. **Why the other options are incorrect:** * **Clarithromycin (B):** Macrolides (Clarithromycin or Azithromycin) are the **cornerstone** of MAC therapy. They inhibit protein synthesis and are essential for both prophylaxis and treatment. * **Rifabutin (C):** This is a rifamycin preferred over Rifampin for MAC because it is more potent against this complex and has fewer drug-drug interactions in HIV patients on HAART. * **Ciprofloxacin (A):** Fluoroquinolones (like Ciprofloxacin or Moxifloxacin) are considered **second-line or adjunctive agents** used in multidrug regimens for macrolide-resistant MAC or disseminated disease. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Regimen for MAC:** Clarithromycin + Ethambutol + Rifabutin. * **Prophylaxis:** In HIV patients with **CD4 counts <50 cells/mm³**, primary prophylaxis with Azithromycin or Clarithromycin is indicated. * **Key Distinction:** Pyrazinamide is only used for *M. tuberculosis*; it is ineffective against almost all Non-Tuberculous Mycobacteria (NTM).

Question 1185: Which of the following antibiotics is not used in the treatment of enterococcal infections?

A. Vancomycin
B. Linezolid
C. Teichoplanin
D. Cephalexin (Correct Answer)

Explanation: **Explanation:** The correct answer is **Cephalexin (Option D)**. The fundamental pharmacological concept to remember for NEET-PG is that **Enterococci are inherently resistant to all Cephalosporins.** This is due to the low affinity of enterococcal Penicillin-Binding Proteins (PBPs), specifically PBP5, for cephalosporins. Therefore, regardless of the generation, cephalosporins (like Cephalexin, a 1st generation agent) are never used to treat enterococcal infections. **Analysis of Options:** * **Vancomycin (Option A):** A glycopeptide that is traditionally the drug of choice for serious ampicillin-resistant enterococcal infections. It inhibits cell wall synthesis by binding to the D-Ala-D-Ala terminus. * **Linezolid (Option B):** An oxazolidinone used primarily for Vancomycin-Resistant Enterococci (VRE). It inhibits protein synthesis by binding to the 50S ribosomal subunit. * **Teicoplanin (Option C):** Another glycopeptide similar to Vancomycin. It is effective against many strains of *Enterococcus faecalis* and *E. faecium*, though some VRE strains (VanA phenotype) are also resistant to it. **High-Yield Clinical Pearls for NEET-PG:** 1. **LAME mnemonic:** Cephalosporins lack activity against **L**isteria, **A**typicals (Mycoplasma/Chlamydia), **M**RSA (except Ceftaroline), and **E**nterococci. 2. **Synergy:** For serious enterococcal infections (e.g., endocarditis), an aminoglycoside (Gentamicin) is added to a cell-wall active agent (Ampicillin or Vancomycin) for bactericidal synergy. 3. **Drug of Choice:** For uncomplicated *E. faecalis*, **Ampicillin** remains the first-line treatment. For VRE, **Linezolid** or **Daptomycin** are preferred.

Question 1186: A 29-year-old female diagnosed with AIDS presents with progressive blurring of vision in her right eye. Fundoscopic examination reveals a small, white, opaque lesion on the retina. What is the most appropriate therapy for this patient?

A. Acyclovir
B. Amantadine
C. Flucytosine
D. Ganciclovir (Correct Answer)

Explanation: The clinical presentation of progressive blurring of vision and a white, opaque retinal lesion in a patient with AIDS is highly suggestive of **CMV Retinitis**. This is the most common opportunistic ocular infection in HIV-infected individuals, typically occurring when the CD4 count falls below 50 cells/mm³ [1, 2]. **1. Why Ganciclovir is Correct:** Ganciclovir is the first-line treatment for CMV infections [1, 2]. It is a guanosine analogue that requires initial phosphorylation by a viral protein kinase (**UL97**) to ganciclovir monophosphate, followed by conversion to the triphosphate form by host cell kinases. This active form competitively inhibits viral DNA polymerase, terminating CMV DNA synthesis. **2. Why Other Options are Incorrect:** * **Acyclovir:** Primarily used for HSV and VZV. It is ineffective against CMV because CMV lacks the viral thymidine kinase required to activate acyclovir. * **Amantadine:** An antiviral agent used for Influenza A (by inhibiting the M2 ion channel) and Parkinson’s disease. It has no activity against DNA viruses like CMV. * **Flucytosine:** An antifungal agent used in combination with Amphotericin B for Cryptococcal meningitis. It has no antiviral properties. **High-Yield Clinical Pearls for NEET-PG:** * **CMV Retinitis Appearance:** Often described as "pizza-pie" or "cottage cheese and ketchup" appearance (hemorrhage with exudates). * **Side Effects:** The dose-limiting toxicity of Ganciclovir is **bone marrow suppression** (neutropenia, thrombocytopenia). * **Alternative Drugs:** If Ganciclovir resistance occurs (UL97 mutation), **Foscarnet** or **Cidofovir** are used; these do not require viral phosphorylation for activation [3]. * **Valganciclovir:** The oral prodrug of ganciclovir, often used for maintenance therapy [3].

Question 1187: Which of the following is NOT a NNRTI?

A. Ritonavir (Correct Answer)
B. Nevirapine
C. Efavirenz
D. Delavirdine

Explanation: The correct answer is **Ritonavir** because it belongs to the **Protease Inhibitor (PI)** class of antiretroviral therapy (ART), not the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) class. ### **Explanation of Options** * **Ritonavir (Option A):** This is a Protease Inhibitor. In modern clinical practice, it is primarily used as a **"pharmacokinetic enhancer" (booster)**. It inhibits the CYP3A4 enzyme, thereby increasing the plasma concentrations and half-life of other protease inhibitors (like Lopinavir or Atazanavir). * **Nevirapine (Option B):** A first-generation NNRTI. It is well-known for its role in preventing mother-to-child transmission of HIV, though it is associated with a high risk of hepatotoxicity and severe skin rashes (Stevens-Johnson Syndrome). * **Efavirenz (Option C):** A first-generation NNRTI. It is a high-yield topic due to its unique side effect profile, including **neuropsychiatric symptoms** (vivid dreams, insomnia, psychosis) and potential teratogenicity (neural tube defects). * **Delavirdine (Option D):** A first-generation NNRTI. It is less commonly used in clinical practice today but remains a classic textbook example of the NNRTI class. ### **High-Yield Clinical Pearls for NEET-PG** 1. **Mechanism of Action:** NNRTIs bind to a **hydrophobic pocket** (allosteric site) on the HIV-1 Reverse Transcriptase enzyme, causing a conformational change. Unlike NRTIs, they do *not* require phosphorylation to become active and do *not* compete with nucleosides. 2. **Class Specificity:** NNRTIs are active only against **HIV-1**, whereas NRTIs and PIs are active against both HIV-1 and HIV-2. 3. **Second Generation NNRTIs:** Remember **Etravirine** and **Rilpivirine**; these are often used when resistance develops to first-generation agents. 4. **Mnemonic for NNRTIs:** "The **NED** family" (**N**evirapine, **E**favirenz, **D**elavirdine).

Question 1188: What is the drug of choice for the treatment of chlamydial infection?

A. Ampicillin
B. Third generation cephalosporins
C. Metronidazole
D. Doxycycline (Correct Answer)

Explanation: **Explanation:** **Chlamydia trachomatis** is an obligate intracellular bacterium, meaning it lacks a traditional peptidoglycan cell wall and resides within host cells. Therefore, the drug of choice must have excellent intracellular penetration and the ability to inhibit bacterial protein synthesis. * **Why Doxycycline is correct:** Doxycycline (a tetracycline) is the **Drug of Choice (DOC)** for uncomplicated genital chlamydial infections. It acts by binding to the 30S ribosomal subunit, inhibiting protein synthesis. According to the latest CDC guidelines, a 7-day course of Doxycycline is preferred over a single dose of Azithromycin due to higher efficacy in eradicating rectal and urethral infections. * **Why other options are incorrect:** * **Ampicillin & 3rd Gen Cephalosporins:** These are Beta-lactams that act by inhibiting cell wall synthesis. Since *Chlamydia* lacks a classic cell wall, these agents are largely ineffective. * **Metronidazole:** This is an antiprotozoal and anaerobic antibacterial agent. It is the DOC for *Trichomonas vaginalis*, Bacterial Vaginosis, and *Entamoeba histolytica*, but has no activity against *Chlamydia*. **High-Yield Clinical Pearls for NEET-PG:** * **Pregnancy:** Doxycycline is contraindicated in pregnancy (causes fetal teeth discoloration). The DOC for Chlamydia in pregnant women is **Azithromycin** (1g orally, single dose). * **Lymphogranuloma Venereum (LGV):** Caused by *C. trachomatis* (L1-L3 serovars), the treatment is Doxycycline for 21 days. * **Syndromic Management:** In the WHO/NACO syndromic approach, Chlamydia is often co-treated with Gonorrhea using a combination of **Ceftriaxone (IM)** and **Azithromycin/Doxycycline (Oral)**.

Question 1189: Clavulanic acid is given in combination with amoxicillin in order to:

A. Reduce the risk of allergic reactions
B. Prolong amoxicillin's half-life
C. Reduce the severity of diarrhea
D. Extend amoxicillin's antibacterial spectrum (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Extend amoxicillin's antibacterial spectrum.** **Mechanism of Action:** Amoxicillin is a beta-lactam antibiotic that is susceptible to degradation by **beta-lactamase enzymes** produced by certain bacteria (e.g., *Staphylococcus aureus*, *H. influenzae*, and *E. coli*). Clavulanic acid is a **"suicide inhibitor"** of beta-lactamase. It has negligible antibacterial activity of its own but binds irreversibly to the beta-lactamase enzyme, protecting amoxicillin from destruction. This allows amoxicillin to inhibit bacterial cell wall synthesis in organisms that would otherwise be resistant, thereby effectively **extending its spectrum** to include beta-lactamase-producing strains. **Analysis of Incorrect Options:** * **A. Reduce allergic reactions:** Clavulanic acid does not modulate the immune system; hypersensitivity reactions (Type I-IV) are inherent to the penicillin structure itself. * **B. Prolong half-life:** The half-life of amoxicillin is determined by renal excretion. Clavulanic acid does not interfere with the renal tubular secretion of amoxicillin (unlike Probenecid, which does). * **C. Reduce diarrhea:** In fact, the combination (Co-amoxiclav) is **more likely** to cause diarrhea and GI upset than amoxicillin alone, as clavulanic acid increases gut motility. **High-Yield NEET-PG Pearls:** * **Other Beta-lactamase Inhibitors:** Sulbactam (paired with Ampicillin) and Tazobactam (paired with Piperacillin). * **Suicide Inhibition:** Clavulanic acid is the classic example where the inhibitor is chemically modified by the enzyme during the process of inhibition. * **Clinical Note:** Co-amoxiclav is a notorious cause of **drug-induced cholestatic jaundice**, a side effect specifically attributed to the clavulanate component.

Question 1190: In cotrimoxazole, what is the ratio of sulphamethoxazole to trimethoprim?

A. 2:1
B. 1:1
C. 5:1 (Correct Answer)
D. 4:5

Explanation: The original explanation provided the answer details without citations. **Cotrimoxazole** is a fixed-dose combination of **Sulphamethoxazole (SMZ)** and **Trimethoprim (TMP)**. [1] The correct ratio in the formulation is **5:1** (e.g., 400 mg SMZ + 80 mg TMP). [3] **1. Why 5:1 is the Correct Answer:** While both drugs act on the same metabolic pathway (folic acid synthesis), they have different pharmacokinetic profiles. [1] Trimethoprim is significantly more lipid-soluble and has a larger volume of distribution than Sulphamethoxazole. To achieve the **optimal synergistic plasma concentration ratio of 20:1** (which is required for maximum bactericidal effect), the drugs must be administered in a **5:1 dose ratio**. [3] This compensates for the difference in their distribution and clearance rates. [4] **2. Analysis of Incorrect Options:** * **A (2:1) & B (1:1):** These ratios would result in insufficient plasma levels of Trimethoprim relative to Sulphamethoxazole, failing to reach the 20:1 steady-state plasma concentration needed for synergy. * **D (4:5):** This is mathematically incorrect and does not align with any standard pharmacological preparation of these agents. [3] **3. NEET-PG High-Yield Clinical Pearls:** * **Mechanism of Action:** Sequential blockade of folate synthesis. [2] SMZ inhibits *Dihydropteroate synthase*, while TMP inhibits *Dihydrofolate reductase*. [1] * **Nature of Action:** Individually, both drugs are bacteriostatic; in combination (Cotrimoxazole), they become **bactericidal**. [2][3] * **Drug of Choice (DOC):** Cotrimoxazole remains the DOC for *Pneumocystis jirovecii* pneumonia and *Stenotrophomonas maltophilia*. [3] * **Adverse Effects:** Watch for Megaloblastic anemia (due to folate deficiency) and Stevens-Johnson Syndrome (due to the sulfonamide component). [3]

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free